Inflammasome-independent NLRP3 augments tgf-b signaling in kidney epithelium

Journal of Immunology

Volumn 190, Issue 3, 2013, Pages 1239-1249

  Wang, Wenjie ^a   Wang, Xiangyu ^a   Chun, Justin ^a   Vilaysane, Akosua ^b   Clark, Sharon ^a   French, Gabrielle ^a   Bracey, Nathan A ^b   Trpkov, Kiril ^b   Bonni, Shirin ^b   Duff, Henry J ^a   Beck, Paul L ^a   Muruve, Daniel A ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; ALPHA SMOOTH MUSCLE ACTIN; APOPTOSIS ASSOCIATED SPECK LIKE PROTEIN CONTAINING A CARD DOMAIN; GELATINASE B; INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; MYELOID DIFFERENTIATION FACTOR 88; NOD LIKE RECEPTOR PYRIN DOMAIN CONTAINING 3 PROTEIN; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; HUMAN; HUMAN CELL; KIDNEY TUBULE EPITHELIUM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; CARRIER PROTEINS; CASPASE 1; CELLS, CULTURED; CYTOKINES; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION; HUMANS; INFLAMMASOMES; INTERLEUKIN-1BETA; KIDNEY TUBULES, PROXIMAL; MATRIX METALLOPROTEINASES; MICE; MICE, INBRED C57BL; NEPHRITIS, INTERSTITIAL; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84872737232     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201959     Document Type: Article

References (46)

1. Collins, A. J., S. Li, J. Z. Ma, and C. Herzog. 2001. Cardiovascular disease in end-stage renal disease patients. Am. J. Kidney Dis. 38(4, Suppl 1)S26-S29. (Pubitemid 32927607)
2. Culleton, B. F., M. G. Larson, J. C. Evans, P. W. F. Wilson, B. J. Barrett, P. S. Parfrey, and D. Levy. 1999. Prevalence and correlates of elevated serum creatinine levels: The Framingham Heart Study. Arch. Intern. Med. 159: 1785-1790. (Pubitemid 29379143)
3. USRDS. 2008. 2007 annual report. http://www.usrds.org/2007.
4. Donadelli, R., M. Abbate, C. Zanchi, D. Corna, S. Tomasoni, A. Benigni, G. Remuzzi, and C. Zoja. 2000. Protein traffic activates NF-kB gene signaling and promotes MCP-1-dependent interstitial inflammation. Am. J. Kidney Dis. 36: 1226-1241.
5. Mezzano, S. A., M. A. Droguett, M. E. Burgos, L. G. Ardiles, C. A. Aros, I. Caorsi, and J. Egido. 2000. Overexpression of chemokines, fibrogenic cytokines, and myofibroblasts in human membranous nephropathy. Kidney Int. 57: 147-158. (Pubitemid 30227762)
6. Vielhauer, V., H. J. Anders, M. Mack, J. Cihak, F. Strutz, M. Stangassinger, B. Luckow, H. J. Grone, and D. Schlondorff. 2001. Obstructive nephropathy in the mouse: Progressive fibrosis correlates with tubulointerstitial chemokine expression and accumulation of CC chemokine receptor 2-and 5-positive leukocytes. J. Am. Soc. Nephrol. 12: 1173-1187. (Pubitemid 32472630)
7. Wada, T., K. Furuichi, N. Sakai, Y. Iwata, K. Yoshimoto, M. Shimizu, S. I. Takeda, K. Takasawa, M. Yoshimura, H. Kida, et al. 2000. Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy. Kidney Int. 58: 1492-1499.
8. Zager, R. A., A. C. Johnson, and K. Becker. 2011. Acute unilateral ischemic renal injury induces progressive renal inflammation, lipid accumulation, histone modification, and "end-stage" kidney disease. Am. J. Physiol. Renal Physiol. 301: F1334-F1345.
9. Becker, G. J., and T. D. Hewitson. 2000. The role of tubulointerstitial injury in chronic renal failure. Curr. Opin. Nephrol. Hypertens. 9: 133-138. (Pubitemid 30131443)
10. Bohle, A., S. Mackensen-Haen, H. von Gise, K. E. Grund, M. Wehrmann, C. Batz, O. Bogenschutz, H. Schmitt, J. Nagy, C. Muller, et al. 1990. The consequences of tubulo-interstitial changes for renal function in glomerulopathies. A morphometric and cytological analysis. Pathol. Res. Pract. 186: 135-144. (Pubitemid 20097957)
11. Rodríguez-Iturbe, B., and G. García García. 2010. The role of tubulointerstitial inflammation in the progression of chronic renal failure. Nephron Clin. Pract. 116: C81-c88.
12. Schroder, K., R. Zhou, and J. Tschopp. 2010. The NLRP3 inflammasome: A sensor for metabolic danger? Science 327: 296-300.
13. Shigeoka, A. A., J. L. Mueller, A. Kambo, J. C. Mathison, A. J. King, W. F. Hall, Jda. S. Correia, R. J. Ulevitch, H. M. Hoffman, and D. B. McKay. 2010. An inflammasome-independent role for epithelial-expressed Nlrp3 in renal ischemia-reperfusion injury. J. Immunol. 185: 6277-6285.
14. Taxman, D. J., E. A. Holley-Guthrie, M. T. Huang, C. B. Moore, D. T. Bergstralh, I. C. Allen, Y. Lei, D. Gris, and J. P. Ting. 2011. The NLR adaptor ASC/PYCARD regulates DUSP10, mitogen-activated protein kinase (MAPK), and chemokine induction independent of the inflammasome. J. Biol. Chem. 286: 19605-19616.
15. Vilaysane, A., J. Chun, M. E. Seamone, W. Wang, R. Chin, S. Hirota, Y. Li, S. A. Clark, J. Tschopp, K. Trpkov, et al. 2010. The NLRP3 inflammasome promotes renal inflammation and contributes to CKD. J. Am. Soc. Nephrol. 21: 1732-1744.
16. Zaki, M. H., K. L. Boyd, P. Vogel, M. B. Kastan, M. Lamkanfi, and T. D. Kanneganti. 2010. The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity 32: 379-391.
17. Ippagunta, S. K., R. K. S. Malireddi, P. J. Shaw, G. A. Neale, L. V. Walle, D. R. Green, Y. Fukui, M. Lamkanfi, and T.-D. Kanneganti. 2011. The inflammasome adaptor ASC regulates the function of adaptive immune cells by controlling Dock2-mediated Rac activation and actin polymerization. Nat. Immunol. 12: 1010-1016.
18. Anders, H. J., and D. A. Muruve. 2011. The inflammasomes in kidney disease. J. Am. Soc. Nephrol. 22: 1007-1018.
19. Martinon, F., A. Mayor, and J. Tschopp. 2009. The inflammasomes: Guardians of the body. Annu. Rev. Immunol. 27: 229-265.
20. Mason, D. R., P. L. Beck, and D. A. Muruve. 2012. Nucleotide-binding oligomerization domain-like receptors and inflammasomes in the pathogenesis of non-microbial inflammation and diseases. J. Innate Immun. 4: 16-30.
21. Liu, Y. 2004. Epithelial to mesenchymal transition in renal fibrogenesis: Pathologic significance, molecular mechanism, and therapeutic intervention. J. Am. Soc. Nephrol. 15: 1-12. (Pubitemid 38020692)
22. Quaggin, S. E., and A. Kapus. 2011. Scar wars: Mapping the fate of epithelialmesenchymal-myofibroblast transition. Kidney Int. 80: 41-50.
23. White, L. R., J. B. Blanchette, L. Ren, A. Awn, K. Trpkov, and D. A. Muruve. 2007. The characterization of alpha5-integrin expression on tubular epithelium during renal injury. Am. J. Physiol. Renal Physiol. 292: F567-F576. (Pubitemid 46220523)
24. Blobe, G. C., W. P. Schiemann, and H. F. Lodish. 2000. Role of transforming growth factor beta in human disease. N. Engl. J. Med. 342: 1350-1358. (Pubitemid 30408720)
25. Bottinger, E. P., and M. Bitzer. 2002. TGF-beta signaling in renal disease. J. Am. Soc. Nephrol. 13: 2600-2610.
26. Lenz, O., S. J. Elliot, andW. G. Stetler-Stevenson. 2000. Matrix metalloproteinases in renal development and disease. J. Am. Soc. Nephrol. 11: 574-581. (Pubitemid 30115088)
27. Trifillis, A. L., A. L. Regec, and B. F. Trump. 1985. Isolation, culture and characterization of human renal tubular cells. J. Urol. 133: 324-329. (Pubitemid 15158441)
28. Martinon, F., V. Pétrilli, A. Mayor, A. Tardivel, and J. Tschopp. 2006. Goutassociated uric acid crystals activate the NALP3 inflammasome. Nature 440: 237-241. (Pubitemid 43372104)
29. Mariathasan, S., K. Newton, D. M. Monack, D. Vucic, D. M. French, W. P. Lee, M. Roose-Girma, S. Erickson, and V. M. Dixit. 2004. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430: 213-218. (Pubitemid 38902430)
30. Kuida, K., J. A. Lippke, G. Ku, M. W. Harding, D. J. Livingston, M. S. Su, and R. A. Flavell. 1995. Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science 267: 2000-2003.
31. Adachi, O., T. Kawai, K. Takeda, M. Matsumoto, H. Tsutsui, M. Sakagami, K. Nakanishi, and S. Akira. 1998. Targeted disruption of the MyD88 gene results in loss of IL-1-and IL-18-mediated function. Immunity 9: 143-150. (Pubitemid 28361303)
32. Wang, W., C. J. Schulze, W. L. Suarez-Pinzon, J. R. Dyck, G. Sawicki, and R. Schulz. 2002. Intracellular action of matrix metalloproteinase-2 accounts for acute myocardial ischemia and reperfusion injury. Circulation 106: 1543-1549.
33. Liu, Y. 2010. New insights into epithelial-mesenchymal transition in kidney fibrosis. J. Am. Soc. Nephrol. 21: 212-222.
34. Page-McCaw, A., A. J. Ewald, and Z. Werb. 2007. Matrix metalloproteinases and the regulation of tissue remodelling. Nat. Rev. Mol. Cell Biol. 8: 221-233.
35. Parks, W. C., C. L. Wilson, and Y. S. López-Boado. 2004. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat. Rev. Immunol. 4: 617-629. (Pubitemid 39025047)
36. Fan, J. M., X. R. Huang, Y. Y. Ng, D. J. Nikolic-Paterson, W. Mu, R. C. Atkins, and H. Y. Lan. 2001. Interleukin-1 induces tubular epithelial- myofibroblast transdifferentiation through a transforming growth factor-beta1-dependent mechanism in vitro. Am. J. Kidney Dis. 37: 820-831. (Pubitemid 32268044)
37. Bani-Hani, A. H., J. A. Leslie, H. Asanuma, C. A. Dinarello, M. T. Campbell, D. R. Meldrum, H. Zhang, K. Hile, and K. K. Meldrum. 2009. IL-18 neutralization ameliorates obstruction-induced epithelial-mesenchymal transition and renal fibrosis. Kidney Int. 76: 500-511.
38. Liang, K. C., C. W. Lee, W. N. Lin, C. C. Lin, C. B. Wu, S. F. Luo, and C. M. Yang. 2007. Interleukin-1beta induces MMP-9 expression via p42/p44 MAPK, p38 MAPK, JNK, and nuclear factor-kappaB signaling pathways in human tracheal smooth muscle cells. J. Cell. Physiol. 211: 759-770.
39. Tobar, N., V. Villar, and J. F. Santibanez. 2010. ROS-NFkappaB mediates TGFbeta1-induced expression of urokinase-type plasminogen activator, matrix metalloproteinase-9 and cell invasion. Mol. Cell. Biochem. 340: 195-202.
40. Di Guglielmo, G. M., C. Le Roy, A. F. Goodfellow, and J. L. Wrana. 2003. Distinct endocytic pathways regulate TGF-beta receptor signalling and turnover. Nat. Cell Biol. 5: 410-421. (Pubitemid 36592263)
41. Artlett, C. M., S. Sassi-Gaha, J. L. Rieger, A. C. Boesteanu, C. A. Feghali-Bostwick, and P. D. Katsikis. 2011. The inflammasome activating caspase 1 mediates fibrosis and myofibroblast differentiation in systemic sclerosis. Arthritis Rheum. 63: 3563-3574.
42. Watanabe, A., M. A. Sohail, D. A. Gomes, A. Hashmi, J. Nagata, F. S. Sutterwala, S. Mahmood, M. N. Jhandier, Y. Shi, R. A. Flavell, and W. Z. Mehal. 2009. Inflammasome-mediated regulation of hepatic stellate cells. Am. J. Physiol. Gastrointest. Liver Physiol. 296: G1248-G1257.
43. Shaw, P. J., J. R. Lukens, S. Burns, H. Chi, M. A. McGargill, and T. D. Kanneganti. 2010. Cutting edge: Critical role for PYCARD/ASC in the development of experimental autoimmune encephalomyelitis. J. Immunol. 184: 4610-4614.
44. Ippagunta, S. K., D. D. Brand, J. Luo, K. L. Boyd, C. Calabrese, R. Stienstra, F. L. Van de Veerdonk, M. G. Netea, L. A. Joosten, M. Lamkanfi, and T. D. Kanneganti. 2010. Inflammasome-independent role of apoptosis-associated speck-like protein containing a CARD (ASC) in T cell priming is critical for collagen-induced arthritis. J. Biol. Chem. 285: 12454-12462.
45. Kolly, L., M. Karababa, L. A. Joosten, S. Narayan, R. Salvi, V. Pétrilli, J. Tschopp, W. B. van den Berg, A. K. So, and N. Busso. 2009. Inflammatory role of ASC in antigen-induced arthritis is independent of caspase-1, NALP-3, and IPAF. J. Immunol. 183: 4003-4012.
46. Ippagunta, S. K., R. K. Malireddi, P. J. Shaw, G. A. Neale, L. V. Walle, Y. Fukui, D. R. Green, M. Lamkanfi, and T. D. Kanneganti. 2012. Addendum: Defective Dock2 expression in a subset of ASC-deficient mouse lines. Nat. Immunol. 13: 701-702.